Last updated: January 24, 2024
Sponsor: Chang Gung Memorial Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lymphedema
Treatment
Patients underwent lymphedema surgery
Patients underwent surgery without LVA
Clinical Study ID
NCT06237907
202201327B0
Ages 20-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Control Group: Patients who have not experienced lymphedema but require surgery due toother diseases such as cancer, trauma, chronic wounds, skin defects, etc.
- Experimental Group: Patients who have lymphedema and undergone lymphedema surgery.
Exclusion
Exclusion Criteria:
- Individuals with venous thrombosis, chronic heart failure, and renal failure.
- Vulnerable populations, individuals with limited mobility, pregnant women, andminors.
- Those expected to be unable to attend follow-up visits or complete the studysmoothly.
- Participants who express doubts about the trial and cannot provide satisfactoryanswers.
Study Design
Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Patients underwent lymphedema surgery
Phase:
Study Start date:
September 20, 2023
Estimated Completion Date:
January 12, 2026
Study Description
Connect with a study center
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung, 83301
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.